Xigduo xr and The flu - a phase IV clinical study of FDA data

Summary:

The flu is reported as a side effect among people who take Xigduo xr (dapagliflozin propanediol; metformin hydrochloride), especially for people who are female, 60+ old, also take Janumet, and have Diabetes.

The phase IV clinical study analyzes which people have The flu when taking Xigduo xr. It is created by eHealthMe based on reports of 2,877 people who have side effects when taking Xigduo xr from the FDA, and is updated regularly.

What is Xigduo xr?

Xigduo xr has active ingredients of dapagliflozin propanediol; metformin hydrochloride. eHealthMe is studying from 2,917 Xigduo xr users. Check the latest studies of Xigduo xr.

What is The flu?

The flu (the flu is caused by an influenza virus) is found to be associated with 2,186 drugs and 2,715 conditions by eHealthMe. Check the latest studies of The flu.

On Apr, 23, 2026

2,877 people reported to have side effects when taking Xigduo xr.
Among them, 14 people (0.49%) have The flu.

Among these 14 people:

What is the gender of people who have The flu when taking Xigduo xr? *

female: 78.57 %
male: 21.43 %

What is the age of people who have The flu when taking Xigduo xr? *

What are other drugs people take besides Xigduo xr? *

What are other side effects people have besides The flu? *

Weakness: 6 people, 42.86%
Nausea (feeling of having an urge to vomit): 5 people, 35.71%
Pain: 5 people, 35.71%
Cough: 4 people, 28.57%
Fatigue (feeling of tiredness): 3 people, 21.43%
Weight Decreased: 3 people, 21.43%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 21.43%
Nasopharyngitis (inflammation of the nasopharynx): 3 people, 21.43%
High Blood Pressure: 3 people, 21.43%
Weight Increased: 3 people, 21.43%

What are the existing conditions these people have? *

Type 2 Diabetes: 3 people, 21.43%
Diabetes: 3 people, 21.43%
Neuroendocrine Tumor: 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Sleep Disorder: 1 person, 7.14%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Pain: 1 person, 7.14%
Neuralgia (pain in one or more nerves): 1 person, 7.14%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 7.14%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Xigduo xr and have The flu?

- Check whether The flu is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xigduo xr:

Xigduo xr (2,917 reports)

The flu treatments and more:

The flu (145,738 reports)

How severe was The flu and when was it recovered:

The flu in Xigduo xr

Expand to all the drugs that have ingredients of dapagliflozin propanediol; metformin hydrochloride:

The flu and drugs with ingredients of dapagliflozin propanediol; metformin hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xigduo xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with The flu:

The flu (2,186 drugs)

Browse all the conditions that are associated with The flu:

The flu (2,715 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dapagliflozin propanediol; metformin hydrochloride (the active ingredients of Xigduo xr) and Xigduo xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.